REGENXBIO Inc. (RGNX)
NASDAQ: RGNX
· Real-Time Price · USD
8.82
-0.24 (-2.65%)
At close: Aug 15, 2025, 3:59 PM
8.91
0.96%
After-hours: Aug 15, 2025, 06:29 PM EDT
REGENXBIO Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 21.36M | 89.01M | 21.21M | 24.2M | 22.3M | 15.62M | 22.21M | 28.91M | 19.98M | 19.14M | 31.34M | 26.51M | 32.65M | 22.22M | 398.65M | 30.77M | 22.04M | 18.88M |
Cost of Revenue | 9.11M | 3.44M | 6.32M | 12.39M | 14.63M | 8.46M | 15.57M | 12.39M | 9.47M | 4.11M | 12.78M | 13.09M | 12.95M | 15.72M | 23.06M | 14.11M | 9.82M | 4.85M |
Gross Profit | 12.24M | 85.58M | 14.9M | 11.81M | 7.67M | 7.16M | 6.64M | 16.53M | 10.5M | 15.03M | 18.56M | 13.42M | 19.7M | 6.5M | 375.6M | 16.67M | 12.22M | 14.03M |
Operating Income | -63.28M | 12.13M | -51.37M | -62.08M | -56.04M | -61.76M | -63.9M | -64.96M | -73.11M | -66.16M | -57.77M | -71.05M | -62.53M | -71.53M | 313.6M | -57.35M | -52.23M | -44.04M |
Interest Income | 3.4M | n/a | 83K | 25K | 29K | 37K | 2.37M | 56K | 40K | 70K | 77K | 18K | 153K | 94K | 19K | 117K | 554K | 29K |
Pretax Income | -70.87M | 6.08M | -51.19M | -59.6M | -52.99M | -63.33M | -63.04M | -61.87M | -72.06M | -66.68M | -59.98M | -75.48M | -68.18M | -76.76M | 307.43M | -58.41M | -57.64M | -50.13M |
Net Income | -70.87M | 6.08M | -51.19M | -59.6M | -52.99M | -63.33M | -62.89M | -61.87M | -72.06M | -69.95M | -59.94M | -79.92M | -68.18M | -76.72M | 294.02M | -58.41M | -57.64M | -50.14M |
Selling & General & Admin | 19.88M | 20.35M | 20.05M | 19.42M | 18.86M | 18.29M | 19.08M | 23.08M | 23.7M | 22.63M | 21.21M | 20.92M | 20.83M | 22.32M | 22.04M | 21.03M | 18.43M | 17.84M |
Research & Development | 55.59M | 53.09M | 50.38M | 54.43M | 44.82M | 50.66M | 51.35M | 58.18M | 59.89M | 58.52M | 62.51M | 63.31M | 61.01M | 55.63M | 47.98M | 47.85M | 45.88M | 39.72M |
Other Expenses | 45K | 15K | -4.17M | 37K | -29K | 34K | -118K | 220K | 26K | 33K | -7.38M | 229K | -391K | 83K | 43.82M | 5.13M | 135K | 515K |
Operating Expenses | 75.52M | 73.45M | 66.26M | 73.89M | 63.7M | 68.92M | 70.54M | 81.49M | 83.61M | 81.18M | 76.33M | 84.46M | 82.23M | 78.03M | 62M | 74.02M | 64.44M | 58.08M |
Interest Expense | 10.99M | -8.57M | 9.42M | 820K | 449K | 1.97M | 1.36M | 1.62M | 1.12M | 2.75M | 4.31M | 5.95M | 6.86M | 6.13M | 6.5M | 6.71M | 6.37M | 6.7M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 84.64M | 76.89M | 72.58M | 86.28M | 78.33M | 77.38M | 86.12M | 93.87M | 93.08M | 85.3M | 89.12M | 97.56M | 95.18M | 93.75M | 85.06M | 88.12M | 74.26M | 62.93M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -152K | n/a | n/a | 3.27M | -43K | 4.44M | n/a | -41K | 13.4M | n/a | n/a | 4K |
Shares Outstanding (Basic) | 51.48M | 51.36M | 50.87M | 50.8M | 50.6M | 45.73M | 44M | 43.95M | 43.53M | 43.45M | 43.3M | 43.25M | 43.11M | 42.94M | 42.77M | 42.63M | 42.51M | 41.82M |
Shares Outstanding (Diluted) | 51.48M | 51.43M | 50.87M | 50.8M | 50.6M | 45.73M | 44M | 43.95M | 43.53M | 43.45M | 43.3M | 43.25M | 43.11M | 42.94M | 44.08M | 42.63M | 42.51M | 41.82M |
EPS (Basic) | -1.38 | 0.12 | -1.01 | -1.17 | -1.05 | -1.38 | -1.43 | -1.41 | -1.66 | -1.61 | -1.38 | -1.85 | -1.58 | -1.79 | 6.87 | -1.37 | -1.36 | -1.2 |
EPS (Diluted) | -1.38 | 0.12 | -1.01 | -1.17 | -1.05 | -1.38 | -1.43 | -1.41 | -1.66 | -1.61 | -1.38 | -1.85 | -1.58 | -1.79 | 6.67 | -1.37 | -1.36 | -1.2 |
EBITDA | -55.97M | 18.61M | -37.75M | -54.82M | -48.49M | -57.18M | -57.34M | -55.87M | -66.51M | -59.74M | -51.54M | -65.98M | -58.68M | -68.04M | 316.2M | -48.87M | -49.07M | -41.5M |
EBIT | -59.88M | 14.65M | -41.77M | -58.78M | -52.54M | -61.36M | -61.68M | -60.24M | -70.94M | -63.92M | -55.67M | -69.53M | -61.32M | -70.63M | 313.6M | -51.7M | -51.27M | -43.43M |
Depreciation & Amortization | 3.9M | 3.96M | 4.02M | 3.96M | 4.05M | 4.18M | 4.33M | 4.37M | 4.43M | 4.18M | 4.13M | 3.55M | 2.64M | 2.59M | 2.61M | 2.83M | 2.2M | 1.93M |